# Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

> **NCT02686398** · PHASE4 · COMPLETED · sponsor: **Korea University Guro Hospital** · enrollment: 174 (actual)

## Conditions studied

- Influenza
- End Stage Renal Failure
- Chronic Kidney Disease

## Interventions

- **BIOLOGICAL:** Fluad
- **BIOLOGICAL:** Agrippal

## Key facts

- **NCT ID:** NCT02686398
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2016-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686398, "Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02686398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*